Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 6,648 call options on the stock. This represents an increase of approximately 289% compared to the average volume of 1,709 call options.
Hedge Funds Weigh In On Semler Scientific
A number of institutional investors and hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets acquired a new stake in Semler Scientific in the 4th quarter valued at about $30,000. Jones Financial Companies Lllp purchased a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $34,000. Larson Financial Group LLC acquired a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $38,000. NewEdge Advisors LLC lifted its position in Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after buying an additional 557 shares in the last quarter. Finally, Summit Securities Group LLC purchased a new position in Semler Scientific during the first quarter worth approximately $32,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Semler Scientific Stock Performance
Shares of SMLR traded up $0.03 during trading hours on Wednesday, hitting $31.53. 741,097 shares of the stock were exchanged, compared to its average volume of 513,580. Semler Scientific has a 12-month low of $21.77 and a 12-month high of $81.56. The company has a market cap of $351.62 million, a price-to-earnings ratio of 6.42 and a beta of 1.42. The stock's 50-day moving average price is $35.72 and its two-hundred day moving average price is $46.07.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The business had revenue of $8.84 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd.
Read Our Latest Stock Report on SMLR
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
